Full Publication List

2012

94.
K. Benesova, M. Vujić Spasić, S. M. Schaefer, J. Stolte, T. Baehr-Ivacevic, K. Waldow, Z. Zhou, U. Klingmueller, V. Benes, M. A. Mall and M. U. Muckenthaler, "Hfe deficiency impairs pulmonary neutrophil recruitment in response to inflammation", PLoS ONE, vol. 7, no. 6, pp. e39363, Jun. 2012.
93.
S. Hübner and J. P. Tuckermann, "Molecular mechanisms of the glucocorticoid receptor in steroid therapy - lessons from transgenic mice", Biomol Concepts, vol. 3, no. 3, pp. 241-253, Jun. 2012.
92.
S. Vandevyver, L. Dejager, T. Van Bogaert, A. Kleyman, Y. Liu, J. P. Tuckermann and C. Libert, "Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation", J. Clin. Invest., vol. 122, no. 6, pp. 2130-2140, Jun. 2012.
91.
M. L. Watson, L. M. Baehr, H. M. Reichardt, J. P. Tuckermann, S. C. Bodine and J. D. Furlow, "A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure", Am. J. Physiol. Endocrinol. Metab., vol. 302, no. 10, pp. E1210-1220, May 2012.
90.
C. Böhm, A. Derer, R. Axmann, U. Hillienhof, M. M. Zaiss, J. Luther, C. Zech, M. Stock, C. Scholtysek, K. Engelke, A. Hess, J. P. Tuckermann, G. Schett and J. P. David, "RSK2 protects mice against TNF-induced bone loss", J. Cell. Sci., vol. 125, no. Pt 9, pp. 2160-2171, May 2012.
89.
S. D. Reichardt, M. Foller, R. Rexhepaj, G. Pathare, K. Minnich, J. P. Tuckermann, F. Lang and H. M. Reichardt, "Glucocorticoids enhance intestinal glucose uptake via the dimerized glucocorticoid receptor in enterocytes", Endocrinology, vol. 153, no. 4, pp. 1783-1794, Apr. 2012.
88.
T. Röszer and G. Banfalvi, "FMRFamide-related peptides: anti-opiate transmitters acting in apoptosis", Peptides, vol. 34, no. 1, pp. 177-185, Mar. 2012.
87.
A. Kleiman, S. Hübner, J. M. Rodriguez Parkitna, A. Neumann, S. Hofer, M. A. Weigand, M. Bauer, W. Schmid, G. Schutz, C. Libert, H. M. Reichardt and J. P. Tuckermann, "Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages", FASEB J., vol. 26, no. 2, pp. 722-729, Feb. 2012.
86.
Z. Stark, G. Gillessen-Kaesbach, M. M. Ryan, I. C. Cirstea, L. Gremer, M. R. Ahmadian, R. Savarirayan and M. Zenker, "Two novel germline KRAS mutations: expanding the molecular and clinical phenotype", Clin. Genet., vol. 81, no. 6, pp. 590-594, 2012.
85.
T. Röszer, The Biology of Subcellular Nitric Oxide. .... Springer Netherlands, 2012.
ISBN:978-94-007-2819-6
84.
S. Seitz, J. Keller, A. F. Schilling, A. Jeschke, R. P. Marshall, B. D. Stride, T. Wintermantel, F. T. Beil, M. Amling, G. Schutz, J. P. Tuckermann and T. Schinke, "Pharmacological estrogen administration causes a FSH-independent osteo-anabolic effect requiring ER alpha in osteoblasts", PLoS ONE, vol. 7, no. 11, pp. e50301, 2012.
83.
M. P. Menendez-Gutierrez, T. Röszer and M. Ricote, "Biology and therapeutic applications of peroxisome proliferator- activated receptors", Curr Top Med Chem, vol. 12, no. 6, pp. 548-584, 2012.

2011

82.
T. Röszer, "Inflammation as death or life signal in diabetic fracture healing", Inflamm. Res., vol. 60, no. 1, pp. 3-10, 2011.
81.
T. Van Bogaert, S. Vandevyver, L. Dejager, F. Van Hauwermeiren, I. Pinheiro, I. Petta, D. Engblom, A. Kleyman, G. Schutz, J. P. Tuckermann and C. Libert, "Tumor necrosis factor inhibits glucocorticoid receptor function in mice: a strong signal toward lethal shock", J. Biol. Chem., vol. 286, no. 30, pp. 26555-26567, 2011.
80.
M. Castoldi, M. Vujić Spasić, S. Altamura, J. Elmen, M. Lindow, J. Kiss, J. Stolte, R. Sparla, L. A. D'Alessandro, U. Klingmueller, R. E. Fleming, T. Longerich, H. J. Grone, V. Benes, S. Kauppinen, M. W. Hentze and M. U. Muckenthaler, "The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice", J. Clin. Invest., vol. 121, no. 4, pp. 1386-1396, 2011.
79.
A. Schmieder, K. Schledzewski, J. Michel, J. P. Tuckermann, L. Tome, C. Sticht, C. Gkaniatsou, J. P. Nicolay, A. Demory, J. Faulhaber, J. Kzhyshkowska, C. Geraud and S. Goerdt, "Synergistic activation by p38 MAPK and glucocorticoid signaling mediates induction of M2-like tumor-associated macrophages expressing the novel CD20 homolog MS4 A8 A", Int. J. Cancer, vol. 129, no. 1, pp. 122-132, 2011.
78.
H. H. Conaway, A. Pirhayati, E. Persson, U. Pettersson, O. Svensson, C. Lindholm, P. Henning, J. P. Tuckermann and U. H. Lerner, "Retinoids stimulate periosteal bone resorption by enhancing the protein RANKL, a response inhibited by monomeric glucocorticoid receptor", J. Biol. Chem., vol. 286, no. 36, pp. 31425-31436, 2011.
77.
E. Polonkai, A. Nagy, I. Csizy, C. Molnar, T. Röszer, G. Balla and T. Jozsa, "Pyloric atresia associated with Dieulafoy lesion and gastric dysmotility in a neonate", J. Pediatr. Surg., vol. 46, no. 10, pp. 19-23, 2011.
76.
A. J. Rose, M. Berriel Diaz, A. Reimann, J. Klement, T. Walcher, A. Krones-Herzig, O. Strobel, J. Werner, A. Peters, A. Kleyman, J. P. Tuckermann, A. Vegiopoulos and S. Herzig, "Molecular control of systemic bile acid homeostasis by the liver glucocorticoid receptor", Cell Metab., vol. 14, no. 1, pp. 123-130, 2011.
75.
M. Jaiswal, L. Gremer, R. Dvorsky, L. C. Haeusler, I. C. Cirstea, K. Uhlenbrock and M. R. Ahmadian, "Mechanistic insights into specificity, activity, and regulatory elements of the regulator of G-protein signaling RGS-containing Rho-specific guanine nucleotide exchange factors GEFs p115, PDZR GEF PRG, and leukemia-associated Rho GEFLARG", J. Biol. Chem., vol. 286, no. 20, pp. 18202-18212, 2011.
74.
N. Schweingruber, A. Haine, K. Tiede, A. Karabinskaya, J. van den Brandt, S. Wust, J. M. Metselaar, R. Gold, J. P. Tuckermann, H. M. Reichardt and F. Luhder, "Liposomal encapsulation of glucocorticoids alters their mode of action in the treatment of experimental autoimmune encephalomyelitis", J. Immunol., vol. 187, no. 8, pp. 4310-4318, 2011.
73.
T. Jozsa, I. Csizy, A. Csiszko, M. Boros, T. Röszer and P. Nyirady, "Double unfurled dartos flap technique in the surgical treatment of recurrent urethrocutaneous fistulas", Urol. Int., vol. 87, no. 4, pp. 380-384, 2011.
72.
Z. Galajda, J. Balla, A. J. Szentmiklosi, T. Biro, G. Czifra, N. Dobrosi, A. Cseppento, L. Patonay, T. Röszer, G. Balla, L. M. Popescu, I. Lekli and A. Tosaki, "Histamine and H1 -histamine receptors faster venous circulation", J. Cell. Mol. Med., vol. 15, no. 12, pp. 2614-2623, 2011.
71.
M. Kraft, I. C. Cirstea, A. K. Voss, T. Thomas, I. Goehring, B. N. Sheikh, L. Gordon, H. Scott, G. K. Smyth, M. R. Ahmadian, U. Trautmann, M. Zenker, M. Tartaglia, A. Ekici, A. Reis, H. G. Dorr, A. Rauch and C. T. Thiel, "Disruption of the histone acetyltransferase MYST 4 leads to a Noonan syndrome-like phenotype and hyperactivated MAPK signaling in humans and mice", J. Clin. Invest., vol. 121, no. 9, pp. 3479-3491, 2011.
70.
A. Rauch, V. Gossye, D. Bracke, E. Gevaert, P. Jacques, K. Van Beneden, B. Vandooren, M. Rauner, L. C. Hofbauer, G. Haegeman, D. Elewaut, J. P. Tuckermann and K. De Bosscher, "An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation", FASEB J., vol. 25, no. 4, pp. 1323-1332, 2011.